Previous       Next       Index

Standardization of the ultrasound classification of hydatic cysts

Over 20 members of the ultrasound (U/S) classification network met in Lisbon, Portugal on Thursday 6 th November, 1997 to discuss the classification that had been developed by members of the network over the previous two years.

A further meeting between a few network members took place in Orlando, USA in December. The overall structure and aims of the classification was generally well accepted and agreed upon. There was some discussion on the order of cyst Types as presented and it was felt that this would be decided upon finally following further studies.

Modifications were made to the classification in order to allow a single cyst Type to be classified irrespective of size, but size will be stratified within each Type. The revised classification will also include information of the decade of life the patient was diagnosed by US in order to examine the possibility of examining changes of cyst appearance with age.

The revised classification is presented in the following pages. The details of description of the different types (with US images) will be sent to the participants in The Network only.It is hoped that network members will provide data from their regional studies to the network coordinator to examine geographical variations in the US Types of the parasite. Any such findings will be published by the network as was done with the clinical treatment of echinococcosis.


WHO classification of ultrasound images in cystic echinococcosis for application in clinical and field epidemiological settings

WHO Informal working group on echinococcosis

Introduction

Since the late 1970's ultrasound (US) has been used for detecting pathological lesions due to a number of parasitic infections including cystic echinococcosis (CE) (King, 1973; Vicary et al, 1977; Babcock et al, 1978; Alltree, 1979; Hadidi, 1979; Macpherson, 1992; Palmer, 1995).

US has more recently been used for the examination of cyst development over time (Romig et al, 1986) and as a means of assessing changes of cysts following chemotherapy (Cossetto et al, 1989) and for surveillance in a hydatid control program (Macpherson et al, 1986).

The introduction of portable US scanners in the mid 1980's facilitated the use of the technique in communities and an increasing number of community based surveys have recently been reported from many parts of the world including Tunisia (Mlika et al, 1986; Bchir et al, 1987; 1991) Libya (Shambesh et al, 1992), East Africa (including Tanzania, Kenya, Sudan, Ethiopia) (Macpherson et al 1987; 1989), Uruguay (Perdomo et al, 1988; Frider et al, 1988) and China (Wang et al, 1991: Chai, 1992; Jiang, 1991).

In contrast to radiology, the grading and staging of pathological conditions detected by US is still evolving. A number of classifications for CE have been previously proposed (Gharbi et al, 1981; Beggs, 1983; Lewall and Mcorkell, 1985; Perdomo et al, 1995; Caremani et al, 1997). Without a standardized classification observations made by different investigators in different endemic settings are not directly comparable.

Longitudinal studies to investigate the natural history of the disease or to follow the natural, or artificial degradation of cysts following chemotherapy, cannot be categorized in a comparable manner. Current classifications also need to be modified to provide a simple grading system for use in a clinical setting. Such a grading system will be useful for physicians using currently acceptable treatment regimes (Pawlowski, 1993; 1997; WHO, 1996). There is therefore the need for a standardised classification to facilitate both the uniform reporting of results from field epidemiological studies as well as in clinical studies conducted in different parts of the world. There is some evidence that the pathology of infection resulting from CE varies between different areas and population groups. For example the majority of cysts in Turkana, Kenya are large, unilocular and fertile (Macpherson et al, 1987). A much more benign strain which usually presents as calcified, small infertile cysts are reported from the northern hemisphere (Wilson et al, 1968; Little et al, 1988; Paul and Stefaniak, 1997). Such variations could depend on the time after infection that they are first diagnosed, intra-species variation of the parasite or from a heterogeneity of behavioral host differences which may be immunological, genetic or nutritional. A standardised classification will facilitate the collection of data to examine variations in pathology in different geographical areas of the world. The WHO classification of CE presented here requires evaluation in both the clinical and field settings. Collaborators are requested to complete Tables 1 and 2.

Pathognomonic signs

The following US images of space occupying lesions in the liver are considered to be pathognomonic diagnostic signs of CE due to Echinococcus granulosis.

  1. Unilocular anechoic lesions which are round or oval with a clear laminated membrane or with snow like inclusions (Type 2)
  2. Multivesicular or multiseptated cysts with a wheel-like appearance (Type 3).
  3. Unilocular cysts with daughter cysts which may present with a honeycomb appearance (Type 3).
  4. Cysts with floating laminated membranes which may also contain daughter cysts (Type 4).

Differential diagnosis of CE

Variations in the prevalence of space occupying lesions due to factors other than CE will complicate the accurate diagnosis of CE by US, particularly in low CE prevalence areas (Macpherson, 1992; Stefaniak, 1997 von Sinner, 1997). It is essential for investigators to report the number of space occupying lesions detected, the number of suspected CE cases and the number confirmed from both clinical and field based settings (Table 2).

Other diagnostic methods

Clinical and laboratory data play as large a role for the correct diagnosis of CE as does ultrasonography, and US results should be evaluated in relation to these findings. Correlation between US and several other diagnostic techniques may not be possible, depending on the availability and quality of facilities in any endemic setting. For a definitive diagnosis of CE in US detected CE images, which have no visible pathognomonic signs, need to be confirmed using one or more alternative diagnostic method. The detection of protoscoleces or hooks on biopsy or from surgical material provides a definitive diagnosis. Fine needle aspiration biopsy (FNAB) can detect specific antigen even in sterile cysts (Stefaniak, 1997). Immunological tests (Craig, 1997), molecular biological techniques (Lightowlers and Gottstein, 1995) also add certainty to a diagnosis. Other non-invasive imaging techniques, for example, CT or MRI are also useful (von Sinner, 1997).

Additional information to be collected during field based US surveys and in a clinical setting.

An important component of US surveys in hospitals and the field are the identification of patients at severe risk from the cysts detected that may require urgent intervention. Such patients may present with existing complications: cysts communicating with the biliary tree, exerting pressure on vital organs or infected cysts. Others may present with a risk of future complications: cysts that may rupture spontaneously or due to trauma, such as large superficial cysts or cysts that may lead to pressure complications.

It is also important to record the biological status of the cysts as revealed by US. These may be classified as active (Group 1: Types 1, 2, 3), transitional (Group 2: Type 4) or inactive (Group 3: Types 5, 6) which may influence the choice of treatment (Table 1).

 

 

Inter and intra-observer variation

Since current scanners generally produce consistent images, the equipment used does not often contribute to variant results. Types of equipment should always be clearly described and its reliability in the field should be reported. Further studies are needed regarding variation between different investigators as well as between different observations by the same investigator at different times. It would also be useful to identify which observations made with the same technique are most frequently subject to variation and to best gauge how the source of this variation can best be avoided.

Evaluation of the WHO classification of CE in the clinical and field based settings

It is important to evaluate the WHO classification in both the clinical and field based settings. In particular its usefulness, appropriateness and ease of use in the different settings. Collaborators are encouraged to evaluate this classification by completing Tables 1 and 2 and sending them with their comments to the network coordinator. ConclusionsThe widening use of US in both health care centers and for community based surveys for the diagnosis of CE necessitates the development of a standardised classification which will facilitate comparative studies from different endemic settings. The classification proposed here by the WHO network took into consideration the most commonly used previous classifications. The classification follows the known natural history pattern of the disease (active, transitional and inactive groups) which will be helpful in a clinical setting. Comparative clinical and field based studies from various parts of the work will help in examining variations in the natural history and possible geographic differences in the parasite. US users in both clinical and field based studies on CE are encouraged to use the proposed standardised classification system as soon as possible.

 

REFERENCES

Alltree M. 1979. Scanning in hydatid disease. Clinical Radiology, 30: 691 - 697.

Babcock D.S., L. Kaufman, I. Cosnow. 1978. Ultrasound diagnosis of hydatid disease (Echinococcosis) in two cases. American Journal of Radiology, 131: 895 - 897.

Bchir A., B. Larouze, H. Bouhaoula, L. Bouden and M. Jemmali. 1987. Echotomographic evidence for a highly endemic focus of hydatidosis in Central Tunisia. Lancet, ii: 684.

Bchir A., B. Larouze, M. Soltani, A. Hamdi, H. Bouhaoula, S. Ducic, A. Ganouni, H. Achour and C. Gaudebout. 1991. Echotomographic and serological population based study of hydatidosis in central Tunisia. Acta Tropica, 49: 149-153.

Beggs I. 1983. The radiological appearances of hydatid disease of the liver. Clinical Radiology, 34: 555 - 563.

Caremani M., A. Benci, R. Maestrini, A. Accorsi, D. Caremani and L. Lapini. 1997. Ultrasound imaging in cystic echinococcosis. Proposal of a new sonographic classification, Acta Tropica, 67: 91 -105.

Chai J. 1992. Seroepidemiology of cystic hydatid disease in Xingjiang Uygur Autonomous Region. Symposium of the First Scientific Conference on Epidemiology of the Five Northwestern Provinces of China, Yinchuan: pp. 42 - 48.

Cossetto B, S. Gruenewald, V. Antico, J.H. Little. 1989. Albendazole treatment of recurrent hydatid disease: serial evaluation with ultrasound. Australia and New Zealand Journal of Surgery, 59: 933 - 936.

Craig, P.S. 1997. Immunodiagnosis of Echinococcus granulosus and a comparison of techniques for diagnosis of canine echinococcosis. In: Anderson, F.L., H. Ouhelli and M. Kachemi (eds), Compendium on cystic echinococcosis in Africa and Middle Eastern countries with special reference to Morocco. Brigham Young UniversityPrint Services, Provo, 85 - 118.

Frider B., C.A. Losada, E. Larrieu and O. Zavaleta. 1988. Asymptomatic abdominal hydatidosis detected by ultrasonography. Acta Radiologica, 29: 431 - 434.

Gharbi H.A., W. Hassine, M.W. Brauner and K. Dupuch. 1981. Ultrasound examination of the hydatic liver. Radiology, 139: 459 - 463.Hadidi A. 1979. Ultrasound findings in liver hydatid cysts. Journal of Clinical Ultrasound, 7: 365 - 368.

Jiang C. 1991. Differential diagnosis between liver Echinococcus cyst and non-Echinococcus cyst. Archivos de la Hidatidosis, 30: 475 - 499.

King D.L. 1973. Ultrasonography of echinococcal cysts. Journal of Clinical Ultrasound, 1: 64.

Lewall D.B. and S.J. McCorkell. 1985. Hepatic echinococcal cysts: sonographic appearance and classification. Radiology, 155: 773 - 775.

Lightowlers, M.W. and Gottstein, B. 1995. Echinococcosis/hydatidosis: antigens, immunological and molecular diagnosis. In: Thompson, R.C.A. and A.J. Lymbery (eds), Echinococcus and hydatid disease. CAB International, Wallingford, 355 - 410.

Little J.M, M.J. Hollands and H. Ekberg. 1988. Recurrence of hydatid disease. World Journal of Surgery, 12: 700 - 704.

Macpherson C.N.L. 1992. Use of ultrasound in the diagnosis of parasitic disease. Tropical Doctor, 22: 14-20.

Macpherson C.N.L., T. Romig, T. Zeyhle, P.H. Rees and J.B.O. Were. 1987. Portable ultrasound scanner versus serology in screening for hydatid cysts in a nomadic population. Lancet, i: 259-261.

Macpherson C.N.L., A. Spoerry, E. Zeyhle, T. Romig and M. Gorfe. 1989. Pastoralists and hydatid disease: an ultrasound scanning prevalence survey in East Africa. Transactions of the Royal Society of Tropical Medicine and Hygiene, 84: 243-247.

Macpherson C.N.L., T. Wachira, E. Zeyhle, T. Romig, C. Macpherson. 1986. Hydatid disease - Research and control in Turkana, Kenya. 1V. The control programme. Transactions of the Royal Society of Tropical Medicine and Hygiene, 80: 196 - 200.

Mlika N., B. Larouze, C. Gaudebout, B. Braham, M. Allegue, M.C. Dazza, M. Dridi, S. Gharbi, B. Gaumer, A. Bchir, J.J. Rousset, M. Delattre and M. Jemmali. 1986. Echotomographic and serologic screening for hydatidosis in a Tunisian village. The American Journal of Tropical Medicine and Hygiene, 35: 815 - 817.

Palmer, P.E.S. (Ed). 1995. Manual on diagnostic ultrasound. World Health Organization, Geneva.Paul, M. and J. Stefaniak, 1997. Detection of specific E. granulosus antigen 5 in liver cyst bioptate human patients. Acta Tropica, 64: 65 - 77.

Pawlowski Z.S. 1993. Critical points in the clinical management of cystic echinococcosis. In: Anderson F.L., J. Chai and F. Liu (eds). Compendium on cystic echinococcosis - with special reference to Xinjiang Uygur Autonomous Region, The People's Republic of China. Provo, UT, Brigham Young University: 119 - 131.

Pawlowski Z.S. 1997. Critical points in the clinical management of cystic echinococcosis: a revised review. In: Andersen F.L., H. Ouhelli and M. Kachani (eds). Compendium on cystic echinococcosis in Africa and in Middle Eastern countries with special reference to Morocco. Provo, UT, Brigham Young University: 119 - 135.

Perdomo R., C. Alvarez, H. Geninazzi, C. Ferreira, J. Monti, R. Parada, Jr., D. Cativelli, A.D. Barrague, E. Rivero and J. Pararda. 1988. Early diagnosis of hydatidosis by ultrasonography. Lancet, 244.

Perdomo R., A. Carbo, C. Alvarez and J. Monti. 1995. Asymptomatic hepatic cystic echinococcosis (hydatidosis) diagnosed by ultrasonography. Echinomed, 19: 2 - 3.

Romig T., E. Zeyhle, C.N.L. Macpherson, P.H. Rees and J.B.O. Were. 1986. Cyst growth and spontaneous cure in hydatid disease. Lancet, ii: 861.

Shambesh M.K., C.N.L. Macpherson, W.N. Beesley, A. Gusby and T. Elsonosi. 1992. Prevalence of human hydatid disease in northwestern Libya: a crossectional ultrasound study. Annals of Tropical Medicine and Parasitology, 86: 381 - 386.

Stefaniak J. 1997. Fine needle aspiration biopsy in the differential diagnosis of the liver cystic echinococcosis: Acta Tropica, 67: 107 - 111.

Vicary F.R., G. Cusick, I.M. Shirley and R.J. Blackwell. 1977. Ultrasound and abdominal hydatid disease. Transactions of the Royal Society Tropical Medicine and Hygiene, 71: 29 - 31.

von Sinner, W.N. 1997. Imaging of cystic echinococcosis. Acta Tropica, 67: 67 - 89.

Wang H., Y. Yin, Z. Ma, C. Zhang, X. Zhang, R. Cheng and R. Jing. 1991. A preliminary report on investigations of both cystic and alveolar forms of human hydatidosis of the liver in Xihou County, Ningxia Province. Chinese Journal of Parasitology and Parasitic Diseases, 9: 143 - 145.

WHO. 1996. Informal working group on echinococcosis. Guidelines for treatment of cystic and alveolar echinococcosis in humans. Bulletin of the World Health Organization 74: 213- 242.

Wilson J.F., A.C. Diddams and R.L. Rausch. 1968. Cystic hydatid disease in Alaska. American Review of Respiratory Diseases, 98: 1 - 15.

 

WHO standardized classification of ultrasound images in CE

 

The following WHO classification system is proposed by the network participants and is related to the most commonly used previous classifications.

Previously published classifications

Proposed WHO classification

Grouping for clinical setting

Gharbi et al 1981

Caremani et al 1997

Perdomo et al 1995

Type I

Type 1 a

Type I

Type 1

Group 1

Active Group

Cysts developing and those larger than 2.0 cm are often fertile

Type I

Type 1 a,b

Type Ia,b,c

Type 2

Type III

Type II a,b

Type 2

Type 3

Type II

Type III a,b

Type IV

Type 3

Type 4

Group 2

Transition Group

Cysts starting to degenerate, but usually still contain viable protoscolices

Type IV

Type V a,b

Type 4,4a

Type 5

Group 3

Inactive Group

Degenerated or partially or totally calcified cysts. Very unlikely to contain viable protoscoleces

Type V

Type VI a,b

Type VII a,b

Type 5,6

Type 6

ASSESSMENT OF THE WHO CLASSIFICATION OF CE FROM CLINICAL

AND FIELD BASED STUDIES

 

Location ............................. Clinical\Field study? ............................. Dates of survey(s) ..................................

Investigator (s) ......................................................................................................................................................

Table 1: Summary of data. Cyst Types and sizes S (small cysts <5.0 cm), M (medium cysts 5 - 10 cm), L ( large cysts >10 cm), and decade of life in which they were first diagnosed by US.

 Type of Cysts

 

 

Decade of life

T1

T2

T3

T4

T5

T6

S

M

L

S

M

L

S

M

L

S

M

L

S

M

L

S

M

L

1

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

2

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

3

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

4

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

5

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

6

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

7

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Total number of space occupying lesions seen ..............

 

For Types 1, 5 and 6 where pathognonomic signs for CE with US are not found please complete Table 2 below.

Table 2: Differential diagnosis of US suspected CE lesions

 

Type of cyst

Number by US alone

Number confirmed by serology

Number confirmed by CT

Number confirmed by MRI

Number confirmed by PAIR/FNAB

Number confirmed by surgery

T1

S

 

 

 

 

 

 

M

 

 

 

 

 

 

L

 

 

 

 

 

 

T2

S

 

 

 

 

 

 

M

 

 

 

 

 

 

L

 

 

 

 

 

 

T3

S

 

 

 

 

 

 

M

 

 

 

 

 

 

L

 

 

 

 

 

 

 

 

Please complete Tables 1 and 2 following the completion of the US survey. If you would like to collaborate with the WHO network on US classification for CE please send the information to the network co-ordinator (Calum Macpherson, P.O. Box 7, St. George's, Grenada, West Indies: Tel: 1 473 444 3068; Fax: 1 473 444 3041; email calum_macpherson@sgu.edu ). The results will be published by the US network and your contribution will be acknowledged. If you have any difficulty with filling in this form or would like to provide further information please contact Calum Macpherson.

Very many thanks for your help.


Page top